Environmental factors associated with Crohn s disease in India

Size: px
Start display at page:

Download "Environmental factors associated with Crohn s disease in India"

Transcription

1 Indian J Gastroenterol (November December 2011) 30(6): DOI /s ORIGINAL ARTICLE Environmental factors associated with Crohn s disease in India Srinivasan Pugazhendhi & Manoj Kumar Sahu & Venkataraman Subramanian & Anna Pulimood & Balakrishnan S. Ramakrishna Received: 7 November 2010 / Accepted: 1 November 2011 / Published online: 13 December 2011 # Indian Society of Gastroenterology 2011 Abstract Background The frequency of diagnosis of Crohn s disease (CD) in India is increasing. This case-control study was designed to detect associations of environmental and dietary factors with the diagnosis of CD. Methods In 200 consecutive patients with CD and 200 control subjects without gastrointestinal disease, environmental hygiene exposures in childhood and in the past one year, and dietary preferences were recorded using a questionnaire. Univariate and multivariate analyses were done. Results In univariate analysis, CD showed positive association with urban residence (at birth and current), availability of protected drinking water (childhood and current), availability of piped water in the house (childhood and current), and strict vegetarian dietary habit, and negative association with regular fish consumption and presence of cattle in the house compound. Multivariate analysis showed that regular fish consumption (OR 0.52, 95% CI , p=0.003), and presence of cattle in the house compound currently (OR 0.57, 95% CI , p=0.023) were significant protective associations, whereas use of safe drinking water was positively associated (OR 1.59, 95% CI , p=0.042) with the disease. See editorial for this article at doi: /s z S. Pugazhendhi : M. K. Sahu : A. Pulimood : B. S. Ramakrishna (*) Department of Gastrointestinal Sciences, Christian Medical College, Vellore , India rama@cmcvellore.ac.in V. Subramanian Wolfson Institute of Digestive Diseases, Nottingham, UK Conclusion Occurrence of CD was associated with dietary and environmental exposures, which indicate that diet and hygiene may influence the development of this disease. Keywords Case-control study. Hygiene. Inflammatory bowel disease Introduction Crohn s disease (CD) was described in the first half of the twentieth century, and its incidence increased dramatically in North America and Europe during the twentieth century [1]. The disease is far less common in the developing world [2, 3], though increasing number of cases are being recognized in recent years [4]. The worldwide increase in CD is paralleled by an increase in the incidence of other auto-inflammatory diseases such as multiple sclerosis, type I diabetes and asthma, and has coincided with a steep reduction in infectious diseases. This shift in disease pattern has been explained using the hygiene hypothesis, according to which immune conditioning by childhood infections protects against inflammatory bowel disease in later life [5, 6]. Environmental factors that have been related to the risk of inflammatory bowel disease include infectious agents, smoking and diet [7]. CD has been shown to be associated with markers of better childhood hygiene, such as birth order, urban residence, separate bedroom as a child, and the availability of hot water taps in the house [8, 9]. Smoking also influences disease course and severity in CD [10]. The risk of CD is also elevated soon after appendicectomy, though this probably reflects diagnostic problems in distinguishing between acute appendicitis and incipient CD [11]. Other exposures postulated to be associated with

2 Indian J Gastroenterol (November December 2011) 30(6): CD include the use of fast foods, cola drinks, toothpaste, antibiotics and oral contraceptives [12]. Thus, both susceptibility genes and environmental factors appear to be strongly involved in the pathogenesis of CD [13]. The incidence of inflammatory bowel disease has increased in Asian countries [14]. Several studies have shown a high incidence and prevalence of CD in South Asian immigrants to the United Kingdom; in particular, among second generation immigrants, the incidence is similar to that in the people of European origin [15 19]. Similar findings have been reported in South Asian migrants to North America [20]. It is postulated that westernization and industrialization with changes in dietary habits and sanitation have contributed to increasing inflammatory bowel disease in Asians [4]. India is undergoing a rapid industrialization, and changes in diet and hygiene, and these changes have been accompanied by an apparent increase in the diagnosis of inflammatory bowel disease [3, 21]. This case-control study tested the hypothesis that lifestyle and hygiene-related environmental factors would be associated with CD in India. Methods Consecutive patients with CD attending the Inflammatory Bowel Diseases Clinic at the Christian Medical College, Vellore between September 2006 and December 2008 were recruited. The diagnosis of CD was based on standard consensus diagnostic criteria [22 24]. Laboratory investigations and imaging studies were done as per the unit s standard clinical protocol. Persons without gastrointestinal disease accompanying patients to the Gastroenterology Clinic of our institution served as control subjects. The controls were not related to the CD patients. For each inflammatory bowel disease (IBD) patient, a person within the same five-year age interval was chosen. Each participant was interviewed by a medical officer, a social worker and a dietician. Clinical and treatment details were ascertained by the medical officer. Socioeconomic status was determined using the modified Kuppuswamy s scale, which is validated for India [25]. This assigns a social score on the basis of education and occupation on a scale of 2 (lowest) to 14 (highest), and an economic score on the basis of family income adjusted for 2007 on a scale of 1 (lowest) to 14 (highest), which are added to yield a composite socioeconomic score (possible range 3 28). Dietary assessment was done using recall of usual dietary practice prior to onset of illness, using food frequency questionnaires relating to foods commonly used in India [26]. A subject was categorized as lacto-vegetarian if he/she never ever ate eggs, meat or fish but consumed milk or milk products, and as a regular consumer of fish or meat, respectively, if he/she ate fish or meat on three or more days every week. Persons using at least ten cigarettes or a packet of beedi per week prior to onset of illness were categorized as smokers. Data on several environmental variables were recorded separately for the childhood period and for the current time. Rural and urban residence was categorized as per the Government of India 1971 census definitions [27]. Nature of the water used for drinking (untreated well water or filtered or boiled water), the availability of water on tap in the house (marking higher level of hygiene than water from a common tap or well located outside the house), the presence of a closed toilet system in the house, the presence of pets in the house, and whether or not the family kept cattle within the compound of the house were recorded and used as surrogate markers of hygiene; these variables were evaluated for the first five years of life (childhood factors) as well as in the past one year (current factors). Although current environmental and dietary factors could have changed in response to the diagnosis of IBD, the data served as a measure of internal consistency. The study protocol was approved by the Research and Ethics Committees of the Christian Medical College, Vellore. Informed written consent was obtained from all participants. Statistical analysis Data are reported as frequencies for categorical variables. Sample size of 200 per group (including correction for incomplete data acquisition) was calculated for comparing CD with controls assuming a two-sided probability of 0.05% and 80% study power to identify factors occurring in a third of controls that would confer a relative risk of 2.0 for CD. Continuous variables were expressed as median (interquartile range) and compared between groups using the Mann- Whitney test. Categorical variables were compared using the chi-square test. The categorical variables that were input included gender, strict vegetarianism, fish consumption, current presence of cattle in the house, residence at birth, current residence, use of filtered or boiled water in childhood, use of filtered or boiled water currently, presence of taps in the house in childhood, presence of taps in the house currently. Age and socioeconomic score were input as continuous variables. Factors that were significantly associated with CD on univariate analysis were entered into a conditional forward logistic regression with the diagnosis as the dependent variable. Odds ratios (OR) and confidence intervals (CI) were calculated for the significant associations. Results The demographic characteristics of the participants are listed in Table 1. Patients with CD had poorer nutrition and

3 266 Indian J Gastroenterol (November December 2011) 30(6): Table 1 Characteristics of patients with Crohn s disease and control subjects Data on continuous variables are shown as median (interquartile range) MUAC mid-upper arm circumference, NS not significant Control subjects (n=200) Crohn s disease (n=200) p-value Age (years) 34 (27 44) 33 (24 45) NS Male gender (n) <0.05 Weight (kg) 55 (49 63) 48 (40 60) <0.001 Height (cm) 157 ( ) 158 ( ) NS MUAC (cm) 24 (23 26) 23 (22 24) <0.001 shorter stature than the reference group. Abdominal pain (153 patients), weight loss (149) and diarrhea (135) were the common presenting symptoms. Nearly half the patients each had blood in stools (92) and fever (98). Sixty-two patients (31%) had joint involvement. The extent of involvement was ileocolonic in 80 patients (40%), colonic in 52 (26%), ileal in 51 (25.5%), and upper gastrointestinal in 17 (8.5%). In 47 patients, the disease was categorized as stricturing and in 35 as penetrating; one hundred and eighteen patients had neither strictures nor penetrating disease. Perianal disease was noted in 37 patients. One hundred and eight patients had received aminosalicylates, 72 corticosteroids and 32 azathioprine; 62 patients (31%) had undergone surgery. Table 2 lists the dietary and personal habits of study participants. Smoking was infrequent and was not associated with CD. Appendicectomy rates were similar in patients with CD and controls (10% vs. 5%, p=0.08). Both groups had only a few lacto-vegetarians but their frequency was higher among patients with CD than in the control group. In contrast, regular consumption of fish was more frequent in the control group (Table 2). The socioeconomic score was marginally higher in the patients with CD (Table 2). Urban residence (birth and current), safe drinking water (childhood and current), and availability of piped water in the house (childhood and current) were all positively associated with a diagnosis of CD (Table 3). Interestingly, the presence of cattle in the house compound currently was negatively associated with diagnosis of CD (Table 3). On multivariate analysis, protective associations were noted with a history of regular fish consumption (OR 0.52, 95% CI , p=0.003) and presence of cattle in the house compound currently (OR 0.57, 95% CI , p=0.023), while the use of treated drinking water was positively and significantly associated with CD (OR 1.59, 95% CI , p=0.042) (Table 4). Discussion This study tried to identify environmental and dietary factors associated with a diagnosis of CD in India. On univariate analysis, several variables related to better hygiene, including urban residence, use of treated drinking water and presence of piped water in the house, were associated with CD. On multivariate analysis, only two hygiene-related variables and one dietary variable were associated with CD. Although these results have to be interpreted with caution since the study was a hospitalbased case-control study, these findings suggest that environmental variables, particularly those in adult life, are associated with CD and may explain the recent increase in diagnosis of CD in India. The clinical presentation and extent of involvement in patients with CD in the present study were similar to those described in a recent multi-center study of 182 Indian patients with CD [28]. The colon was involved in about two-thirds (along with the ileum in 40%) of our patients. The higher prevalence of ileocolonic involvement in Asian patients with CD has been previously commented upon [4]. Isolated ileal disease was seen in only about a quarter of patients, an observation consistent with the rarity of commonly described NOD2 mutations in the Indian population [29, 30]. Table 2 Socioeconomic, past medical history, dietary preferences and personal habits of study participants NS not significant Controls (n=200) CD (n=200) p-value Socioeconomic score (median [interquartile range]) 20 (16 24) 22 (18 26) Pulmonary tuberculosis in past (n) 3 11 NS Appendicectomy (n) NS Smoking history (n) NS Lacto-vegetarian (n) Regular fish consumption (n) Regular meat consumption (n) NS

4 Indian J Gastroenterol (November December 2011) 30(6): Table 3 Environmental variables related to hygiene in patients with Crohn s disease Variable Crohn s disease Control Odds ratio 95% CI p-value Urban residence At birth 88/112 63/ Past 1 year 126/74 97/ Treated drinking water Childhood 24/174 8/ Past 1 year 83/115 57/ Piped water in house Childhood 69/130 47/ Past 1 year 124/72 98/ Closed toilet in house Childhood 101/83 97/ NS Past 1 year 186/13 182/ NS Tooth cleanser use Childhood 149/49 146/ NS Past 1 year 198/2 191/ NS Pets in house Childhood 44/151 53/ NS Past 1 year 30/167 27/ NS Cattle in house compound Childhood 91/ / NS Past 1 year 38/156 66/ Data are numbers of participants answering yes / no to each question. Missing numbers indicate that participants were uncertain of the answer and responded do not know NS not significant Interestingly, smoking, which is consistently associated with risk of CD in other populations, was not associated with CD in our patients. Smoking is associated with more severe illness and continuing inflammation in CD patients. In a Dutch cohort, the NOD2 (R702W) mutation (along with several other SNPs - rs , rs and rs ) was associated with CD only in smokers [31]. Whereas the prevalence of the latter SNPs in the Indian population is not known, the NOD2 (R702W) mutation is rare or absent [29, 30]. This may explain the lack of association between CD and smoking in our patients. The appendicectomy rate was 5% in our control group (compared to a rate of 1.3% in Sweden [32]) and showed a trend to be higher (10%, p=0.08) in patients with CD. A recent meta analysis showed a positive association of appendicectomy with CD in the early stages of the illness, possibly because some patients with early CD undergo surgery with a mistaken diagnosis of acute appendicitis [11]. Diet may play a significant role in the genesis of CD, probably through effects on the gut microbiota. In our study, the number of strict lacto-vegetarians though small, was somewhat higher in patients with CD than in controls. Regular consumption of fish, on the other hand, was negatively associated with CD. In the multivariate analysis, only the latter association was observed. Though the interviewer in our study did try to specifically target dietary preference prior to the diagnosis of CD, we cannot be certain that these associations could not have resulted from dietary changes following the diagnosis of CD. Our findings parallel the finding of a protective association of diets containing fish with CD in children in a previous study [33]. Fish oils are rich in omega-3 long chain polyunsaturated fatty acids which can get incorporated into cell membranes, reducing the availability of arachidonic acid for the synthesis of pro-inflammatory eicosanoids. Indeed, administration of fish oils to patients with inflammatory bowel diseases has been shown to alter the profile of inflammatory mediators in the gastrointestinal mucosa [34]. On the other hand, a meta analysis of intervention trials did not support a role for fish oils in the maintenance of remission in CD [35]. Surrogate markers of better hygiene in childhood were positively associated with CD in univariate analysis; however, on multivariate analysis, the only significantly associated factors pertained to adult life including the use of Table 4 Multivariate analysis of association between environmental variables and Crohn s disease Variable Odds ratio 95% confidence interval p-value Consumption of fish more than once a week Presence of cattle in the compound of the house currently Current use of filtered or boiled water

5 268 Indian J Gastroenterol (November December 2011) 30(6): treated drinking water, presence of cattle in the house compound, and regular consumption of fish. Interestingly, a recent investigation in Spain also identified adult-life hygiene factors (urban residence, social status and education) rather than childhood hygiene factors to be associated with CD [36]. The original hygiene hypothesis proposed the association of CD with hygiene-related variables during early childhood, leading to loss of oral tolerance [7, 9]. According to a recent alternative explanation, hygiene variables are related to alterations in the intestinal microbiota, which tilt the balance away from tolerance and towards intestinal inflammation [6]. In the present study, presence of cattle within the house compound was inversely associated with CD. A previous study reported that residence on a farm was negatively associated with CD [37]. We have previously shown that the fecal flora of rural children and adults living in close proximity to cattle contain the ruminal microbe, Butyrivibrio fibrisolvens [38], which is a major producer of butyrate and other short chain fatty acids. This microbe may exert probiotic effects in the human gastrointestinal tract, helping maintain immune homeostasis and preventing bowel inflammation. Several limitations of the study design need to be recognized. There were significant gender differences between cases and controls, with more males among the controls than among the cases. However, the multivariate analysis showed that there were associations that were independent of gender. The fact this was a hospital-based study was a limitation. Ideally, epidemiological associations should use community-based cases and controls with an excess of controls. In other countries, these are done using population-based registries. However, CD continues to be rare in our country, there is no population-based registry, and community sampling would require enormous numbers to be screened. Under the circumstances, it appears reasonable to conduct a hospital-based case-control study as any epidemiological associations would be best understood during the process of health transition that India is undergoing presently. The issue of recall bias troubles all case-control studies. We asked for recall of childhood practices as well as current practices. There was reasonable concordance between childhood practices (e.g., eating fish, use of safe drinking water) and current practices which provided a degree of internal validation of the findings. While the study findings must be interpreted within these limitations, we believe that these are moderately robust, because these appear biologically plausible. In conclusion, our study documents the environmental associations of CD that relate predominantly to hygiene and diet in adult life. These findings are consistent with the recent suggestions that alterations in intestinal microbiota in adult life, rather than changes in immune conditioning in early childhood, explain the hygiene hypothesis in relation to causation of CD. Acknowledgements This study was supported by a grant-in-aid from the Washington University School of Medicine, St. Louis, USA. The authors wish to thank Dr. Joshua Korzenik (Massachussetts General Hospital, Boston, MA, USA) who was responsible for generating this grant and for supporting this activity. Author contributions SP contributed to supervision and data analysis; MKS contributed to data collation and analysis; VS to design of study and data collection; AP to histological diagnosis, and BSR to design, overall supervision, data analysis, and writing up the paper. References 1. Kirsner JB. Historical aspects of inflammatory bowel disease. J Clin Gastroenterol. 1988;10: Economou M, Pappas G. New global map of Crohn s disease: genetic, environmental, and socioeconomic correlations. Inflamm Bowel Dis. 2008;14: Sood A, Midha V. Epidemiology of inflammatory bowel disease in Asia. Indian J Gastroenterol. 2007;26: Thia KT, Loftus EV Jr, Sandborn WJ, et al. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gastroenterol. 2008;103: Strachan DP. Hay fever, hygiene and household size. Br Med J. 1989;299: Guarner F, Bourdet-Sicard R, Brandtzaeg P, et al. Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol. 2006;3: Timmer A. Environmental influences on inflammatory bowel disease manifestations. lessons from epidemiology. Dig Dis. 2003;21: Gent AE, Hellier MD, Grace RH, et al. Inflammatory bowel disease and domestic hygiene in infancy. Lancet. 1994;343: Klement E, Lysy J, Hoshen M, et al. Childhood hygiene is associated with the risk for inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2008;103: Thomas GA, Rhodes J, Green JT. Inflammatory bowel disease and smoking a review. Am J Gastroenterol. 1998;93: Kaplan GG, Jackson T, Sands BE, Frisch M, Andersson RE, Korzenik J. The risk of developing Crohn s disease after an appendectomy: a meta-analysis. Am J Gastroenterol. 2008;103: Ekbom A, Montgomery SM. Environmental risk factors (excluding tobacco and microorganisms): critical analysis of old and new hypotheses. Best Pract Res Clin Gastroenterol. 2004;18: de Mesquita MB, Civitelli F, Levine A. Epidemiology, genes and inflammatory bowel diseases in childhood. Dig Liver Dis. 2008;40: Ouyang Q, Tandon R, Goh KL, et al. The emergence of inflammatory bowel disease in the Asian Pacific region. Curr Opin Gastroenterol. 2005;21: Jayanthi V, Probert CS, Pinder D, et al. Epidemiology of Crohn s disease in Indian migrants and the indigenous population in Leicestershire. Q J Med. 1992;82: Probert CS, Jayanthi V, Pinder D, et al. Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut. 1992;33: Montgomery SM, Morris DL, Pounder RE, et al. Asian ethnic origin and the risk of inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1999;11:543 6.

6 Indian J Gastroenterol (November December 2011) 30(6): Carr I, Mayberry JF. The effects of migration on ulcerative colitis: a three-year prospective study among Europeans and first- and second- generation South Asians in Leicester ( ). Am J Gastroenterol. 1999;94: Tsironi E, Feakins RM, Probert CS, et al. Incidence of inflammatory bowel disease is rising and abdominal tuberculosis is falling in Bangladeshis in East London, United Kingdom. Am J Gastroenterol. 2004;99: Pinsk V, Lemberg DA, Grewal K, et al. Inflammatory bowel disease in the South Asian pediatric population of British Columbia. Am J Gastroenterol. 2007;102: Yang SK, Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease in Asia. Inflamm Bowel Dis. 2001;7: Ouyang Q, Tandon R, Goh KL, et al. Management consensus of inflammatory bowel disease for the Asia-Pacific region. J Gastroenterol Hepatol. 2006;21: Pulimood AB, Peter S, Ramakrishna B, et al. Segmental colonoscopic biopsies in the differentiation of ileocolic tuberculosis from Crohn s disease. J Gastroenterol Hepatol. 2005;20: Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19 Suppl A: Kumar N, Shekhar C, Kumar P, Kundu AS. Kuppuswamy s socioeconomic status scale updating for Indian J Pediatr. 2007;74: Gopalan C, Rama Sastri BV, Balasubramanian SC. Nutritive Values of Indian Foods. Indian Council of Medical Research, 2004, New Delhi perceptive_link/census_terms_link/censusterms.html. Accessed on 04/18/ Das K, Ghoshal UC, Dhali GK, et al. Crohn s disease in India: a multicenter study from a country where tuberculosis is endemic. Dig Dis Sci. 2009;54: Juyal G, Amre D, Midha V, et al. Evidence of allelic heterogeneity for associations between the NOD2/CARD15 gene and ulcerative colitis among North Indians. Aliment Pharmacol Ther. 2007;26: Pugazhendhi S, Amte A, Balamurugan R, et al. Common NOD2 mutations are absent in patients with Crohn s disease in India. Indian J Gastroenterol. 2008;27: van der Heide F, Nolte IM, Kleibeuker JH, et al. Differences in genetic background between active smokers, passive smokers, and non-smokers with Crohn s disease. Am J Gastroenterol. 2010;105: Blomqvist PG, Andersson RE, Granath F, et al. Mortality after appendectomy in Sweden, Ann Surg. 2001;233: D Souza S, Levy E, Mack D, et al. Dietary patterns and risk for Crohn s disease in children. Inflamm Bowel Dis. 2008;14: Calder PC. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res. 2008;52: Turner D, Zlotkin SH, Shah PS, Griffiths AM. Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn s disease. Cochrane Database Syst Rev. 2009;(1): CD López-Serrano P, Pérez-Calle JL, Pérez-Fernández MT, Fernández- Font JM, Boixeda de Miguel D, Fernández-Rodríguez CM. Environmental risk factors in inflammatory bowel diseases. Investigating the hygiene hypothesis: a Spanish case-control study. Scand J Gastroenterol. 2010;45: Bernstein CN, Rawsthorne P, Cheang M, et al. A populationbased case control study of potential risk factors for IBD. Am J Gastroenterol. 2006;101: Balamurugan R, Aarthi CM, Chittaranjan SP, et al. Molecular detection of the ruminal bacterium, Butyrivibrio fibrisolvens, in feces from rural residents of southern India. Microbial Ecol Health Dis. 2009;21:38 43.

Accepted Manuscript. Does eradication of Helicobacter pylori cause inflammatory bowel disease? Johan Burisch, Tine Jess

Accepted Manuscript. Does eradication of Helicobacter pylori cause inflammatory bowel disease? Johan Burisch, Tine Jess Accepted Manuscript Does eradication of Helicobacter pylori cause inflammatory bowel disease? Johan Burisch, Tine Jess PII: S1542-3565(19)30153-3 DOI: https://doi.org/10.1016/j.cgh.2019.02.013 Reference:

More information

Differentiation Between Ileocecal Tuberculosis and Crohn s Disease using a Combination of Clinical, Endoscopic and Histological Characteristics

Differentiation Between Ileocecal Tuberculosis and Crohn s Disease using a Combination of Clinical, Endoscopic and Histological Characteristics 38 Original Article Differentiation Between Ileocecal Tuberculosis and Crohn s Disease using a Combination of Clinical, Endoscopic and Histological Characteristics Anuchapreeda S Leelakusolvong S Charatcharoenwitthaya

More information

Predicting the natural history of IBD. Séverine Vermeire, MD, PhD Department of Gastroenterology University Hospital Leuven Belgium

Predicting the natural history of IBD. Séverine Vermeire, MD, PhD Department of Gastroenterology University Hospital Leuven Belgium Predicting the natural history of IBD Séverine Vermeire, MD, PhD Department of Gastroenterology University Hospital Leuven Belgium Patient 1 Patient 2 Age 22 Frequent cramps and diarrhea for 6 months Weight

More information

History of IBD in India

History of IBD in India History of IBD in India 1 History before History 1769 : Morgagni : gave the first description of Crohn s Disease 1865 : First description of Ulcerative colitis recorded in Annals of Union Army Medical

More information

Environmental factors affecting IBD Have we made progress? Peter Laszlo Lakatos 1st Department of Medicine Semmelweis University Budapest Hungary

Environmental factors affecting IBD Have we made progress? Peter Laszlo Lakatos 1st Department of Medicine Semmelweis University Budapest Hungary Environmental factors affecting IBD Have we made progress? Peter Laszlo Lakatos 1st Department of Medicine Semmelweis University Budapest Hungary Environmental factors in IBD Are associated with disease

More information

Genetic and Environmental Risks for IBD

Genetic and Environmental Risks for IBD Genetic and Environmental Risks for IBD CCFA April 26, 2014 Presented by: Name goes here April 30, 2014 TheoTheodore 1 Genetic and Environmental Risks for IBD Theodore M. Bayless, M.D. Director Emeritus

More information

Factsheet - Risk factors for inflammatory bowel disease (IBD)

Factsheet - Risk factors for inflammatory bowel disease (IBD) Key Points Knowledge of the causes or risk factors for Crohn s disease and ulcerative colitis is limited. Many genes have been shown to be associated with the development of IBD. Research is continuing

More information

ESPEN Congress Lisbon 2015 NUTRITIONAL ISSUES IN CROHN'S DISEASE. The clash of generations: children are not small adults S.

ESPEN Congress Lisbon 2015 NUTRITIONAL ISSUES IN CROHN'S DISEASE. The clash of generations: children are not small adults S. ESPEN Congress Lisbon 2015 NUTRITIONAL ISSUES IN CROHN'S DISEASE The clash of generations: children are not small adults S. Kolacek (HR) Role of Nutrition in Children with CD Child is NOT a Little Adult

More information

Medical Therapy for Pediatric IBD: Efficacy and Safety

Medical Therapy for Pediatric IBD: Efficacy and Safety Medical Therapy for Pediatric IBD: Efficacy and Safety Betsy Maxwell, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition Pediatric IBD: Defining Remission

More information

Efficacy and Safety of Treatment for Pediatric IBD

Efficacy and Safety of Treatment for Pediatric IBD Efficacy and Safety of Treatment for Pediatric IBD Andrew B. Grossman MD Co-Director, Center for Pediatric Inflammatory Bowel Disease Associate Professor of Clinical Pediatrics Division of Gastroenterology,

More information

Crohn s Disease. Naturopathic Treatment Options

Crohn s Disease. Naturopathic Treatment Options Crohn s Disease Naturopathic Treatment Options by Dr. Gayamali Karunaratna, B.Sc., M.Ed., ND Markham Natural Health Centre 3160 Steeles Avenue East, Suite 204 Markham, Ontario L3R 4G9 http://www.markhamnaturalhealthcentre.com

More information

Is there an anti-inflammatory diet in IBD?

Is there an anti-inflammatory diet in IBD? CCFA North Texas Chapter IBD education symposium December 2, 2017, Dallas, TX Is there an anti-inflammatory diet in IBD? Themos Dassopoulos, MD Director, Baylor Scott and White Center for IBD Baylor University

More information

Gut Microbiota and IBD. Vahedi. H M.D Associate Professor of Medicine DDRI

Gut Microbiota and IBD. Vahedi. H M.D Associate Professor of Medicine DDRI Gut Microbiota and IBD Vahedi. H M.D Associate Professor of Medicine DDRI 1393.3.1 2 GUT MICROBIOTA 100 Trillion Microbes - 10 times more than cells in our body Collective weight of about 1kg in human

More information

Page 1. Is the Risk This High? Dysplasia in the IBD Patient. Dysplasia in the Non IBD Patient. Increased Risk of CRC in Ulcerative Colitis

Page 1. Is the Risk This High? Dysplasia in the IBD Patient. Dysplasia in the Non IBD Patient. Increased Risk of CRC in Ulcerative Colitis Screening for Colorectal Neoplasia in Inflammatory Bowel Disease Francis A. Farraye MD, MSc Clinical Director, Section of Gastroenterology Co-Director, Center for Digestive Disorders Boston Medical Center

More information

PEDIATRIC INFLAMMATORY BOWEL DISEASE

PEDIATRIC INFLAMMATORY BOWEL DISEASE PEDIATRIC INFLAMMATORY BOWEL DISEASE Alexis Rodriguez, MD Pediatric Gastroenterology Advocate Children s Hospital Disclosers Abbott Nutrition - Speaker Inflammatory Bowel Disease Chronic inflammatory disease

More information

Recent Advances in the Management of Refractory IBD

Recent Advances in the Management of Refractory IBD Recent Advances in the Management of Refractory IBD Raina Shivashankar, M.D. Assistant Professor of Medicine Division of Gastroenterology and Hepatology Thomas Jefferson University Philadelphia, PA Outline

More information

Fibrotic complications of inflammatory bowel disease

Fibrotic complications of inflammatory bowel disease January 27th 2017, 8th Gastro Foundation Weekend for Fellows; Spier Hotel & Conference Centre, Stellenbosch Fibrotic complications of inflammatory bowel disease Gerhard Rogler, Department of Gastroenterology

More information

Environmental exposure: can we reduce risk?

Environmental exposure: can we reduce risk? Oxford Inflammatory Bowel Disease MasterClass Environmental exposure: can we reduce risk? Dr Peter Lakatos, Budapest, Hungary Oxford Inflammatory Bowel Disease MasterClass Environmental exposure: can we

More information

East west gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort

East west gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort East west gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort diseasespictures.com Balazs Radnai and Martin Eigler Statistik II. Course 27.01.2014. Introduction

More information

Can We Predict the Natural History of Ulcerative Colitis? Edward V Loftus, Jr, MD Professor of Medicine Mayo Clinic Rochester, Minnesota, USA

Can We Predict the Natural History of Ulcerative Colitis? Edward V Loftus, Jr, MD Professor of Medicine Mayo Clinic Rochester, Minnesota, USA Can We Predict the Natural History of Ulcerative Colitis? Edward V Loftus, Jr, MD Professor of Medicine Mayo Clinic Rochester, Minnesota, USA Endpoints Overview Hospitalization Surgery Colorectal cancer

More information

Efficacy and Safety of Treatment for Pediatric IBD

Efficacy and Safety of Treatment for Pediatric IBD Efficacy and Safety of Treatment for Pediatric IBD Andrew B. Grossman MD Co-Director, Center for Pediatric Inflammatory Bowel Disease Assistant Professor of Clinical Pediatrics Division of Gastroenterology,

More information

EFFECT OF SMOKING ON BODY MASS INDEX: A COMMUNITY-BASED STUDY

EFFECT OF SMOKING ON BODY MASS INDEX: A COMMUNITY-BASED STUDY ORIGINAL ARTICLE. EFFECT OF SMOKING ON BODY MASS INDEX: A COMMUNITY-BASED STUDY Pragti Chhabra 1, Sunil K Chhabra 2 1 Professor, Department of Community Medicine, University College of Medical Sciences,

More information

Safety and Efficacy of Endoscopic Dilatation of Strictures in Crohn s Disease

Safety and Efficacy of Endoscopic Dilatation of Strictures in Crohn s Disease Safety and Efficacy of Endoscopic Dilatation of Strictures in Crohn s Disease Vinna An, Ashwinna Asairinachan, Michael Johnston, James Keck, Paul Salama, Steven Brown, Rodney Woods Department of Colorectal

More information

Running head: CHRON'S DISEASE GENE-ENVIRONMENTAL INTERACTION 1

Running head: CHRON'S DISEASE GENE-ENVIRONMENTAL INTERACTION 1 Running head: CHRON'S DISEASE GENE-ENVIRONMENTAL INTERACTION 1 A review of Crohn's Disease Gene-Environmental Interaction A study of gene-environment interaction between genetic susceptibility variants

More information

Crohn s Disease: Should We Treat Based on Symptoms or Based on Objective Markers of Inflammation?

Crohn s Disease: Should We Treat Based on Symptoms or Based on Objective Markers of Inflammation? Crohn s Disease: Should We Treat Based on Symptoms or Based on Objective Markers of Inflammation? Edward V. Loftus, Jr., M.D. Professor of Medicine Division of Gastroenterology and Hepatology Mayo Clinic

More information

Epidemiology of Inflammatory Bowel Disease and Overview of Pathogenesis

Epidemiology of Inflammatory Bowel Disease and Overview of Pathogenesis Epidemiology of Inflammatory Bowel Disease and Overview of Pathogenesis Crohn s disease (CD) and ulcerative colitis (UC) are believed to affect approximately 1.4 million people in the United States (US).

More information

Looking for Answers. IBD Research March 9, Dr. Benjamin Click, MD MS Associate Staff Cleveland Clinic

Looking for Answers. IBD Research March 9, Dr. Benjamin Click, MD MS Associate Staff Cleveland Clinic Looking for Answers IBD Research 2019 March 9, 2019 Dr. Benjamin Click, MD MS Associate Staff Cleveland Clinic Disclosures No relevant financial disclosures There is still no cure for IBD Why me? ETIOLOGY

More information

Faecalibacterium prausnitzii

Faecalibacterium prausnitzii Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients PNAS 105(43): 16731-16736, 2008. Speaker: Ming-Cheng Chen Advisor:

More information

Initiation of Maintenance Treatment in Moderate to Severe New Onset Crohn s Disease

Initiation of Maintenance Treatment in Moderate to Severe New Onset Crohn s Disease Initiation of Maintenance Treatment in Moderate to Severe New Onset Crohn s Disease The Case for Starting with Anti-TNFα Agents Maria Oliva-Hemker, M.D. Chief, Division of Pediatric Gastroenterology &

More information

Nutritional Requirements for Inflammatory Bowel Disease. Dale Lee, MD, MSCE Assistant Professor of Pediatrics University of Washington

Nutritional Requirements for Inflammatory Bowel Disease. Dale Lee, MD, MSCE Assistant Professor of Pediatrics University of Washington Nutritional Requirements for Inflammatory Bowel Disease Dale Lee, MD, MSCE Assistant Professor of Pediatrics University of Washington No disclosures Objectives 1) Review the biological mechanisms disturbed

More information

Factors Influencing Smoking Behavior Among Adolescents

Factors Influencing Smoking Behavior Among Adolescents RESEARCH COMMUNICATION Factors Influencing Smoking Behavior Among Adolescents Urmi Sen 1, Arindam Basu 2 Abstract Objective To study the impact of tobacco advertisements and other social factors on the

More information

Inflammatory Bowel Disease: Clinical updates. Dr Jeff Chao Princess Alexandra Hospital

Inflammatory Bowel Disease: Clinical updates. Dr Jeff Chao Princess Alexandra Hospital Inflammatory Bowel Disease: Clinical updates Dr Jeff Chao Princess Alexandra Hospital Inflammatory bowel disease 2017 Clinical updates and future directions Pathogenesis Treatment targets Therapeutic agents

More information

Position of Biologics in IBD Circa 2006: Top Down vs. Step Up Therapy

Position of Biologics in IBD Circa 2006: Top Down vs. Step Up Therapy Position of Biologics in IBD Circa 2006: Top Down vs. Step Up Therapy Stephen B. Hanauer, MD University of Chicago Potential Conflicts: Centocor/Schering, Abbott, UCB, Elan, Berlex, PDL Goals of Treatment

More information

Inflammatory Bowel Disease Cohort Studies in Korea: Present and Future

Inflammatory Bowel Disease Cohort Studies in Korea: Present and Future SPECIAL REVIEW: IBD and Epidemiology in Asia ISSN 1598-9100(Print) ISSN 2288-1956(Online) http://dx.doi.org/10.5217/ir.2015.13.3.213 Intest Res 2015;13(3):213-218 Inflammatory Bowel Disease Cohort Studies

More information

Spectrum of Diverticular Disease. Outline

Spectrum of Diverticular Disease. Outline Spectrum of Disease ACG Postgraduate Course January 24, 2015 Lisa Strate, MD, MPH Associate Professor of Medicine University of Washington, Seattle, WA Outline Traditional theories and updated perspectives

More information

Crohn disease is a chronic inflammatory bowel disease

Crohn disease is a chronic inflammatory bowel disease GASTROENTEROLOGY 2010;139:1147 1155 Risk Factors Associated With Progression to Intestinal Complications of Crohn s Disease in a Population-Based Cohort KELVIN T. THIA,*, WILLIAM J. SANDBORN,* WILLIAM

More information

Disease behavior in adult patients- are there predictors for stricture or fistula formation?

Disease behavior in adult patients- are there predictors for stricture or fistula formation? Disease behavior in adult patients- are there predictors for stricture or fistula formation? Falk Symposium 168, Madrid, Spain Iris Dotan, M.D., Head, IBD Center, Department of Gastroenterology and Liver

More information

Positioning Biologics in Ulcerative Colitis

Positioning Biologics in Ulcerative Colitis Positioning Biologics in Ulcerative Colitis Bruce E. Sands, MD, MS Acting Chief, Gastrointestinal Unit Massachusetts General Hospital Associate Professor of Medicine Harvard Medical School Sequential Therapies

More information

Trends in Second-Hand Tobacco Smoke Exposure Levels at Home among Viet Nam School Children Aged and Associated Factors

Trends in Second-Hand Tobacco Smoke Exposure Levels at Home among Viet Nam School Children Aged and Associated Factors RESEARCH ARTICLE Trends in Second-Hand Tobacco Smoke Exposure Levels at Home among Viet Nam School Children Aged 13-15 and Associated Factors Nguyen Tuan Lam 1, Pham Thi Quynh Nga 1 *, Hoang Van Minh 2,

More information

Dietary Options for Inflammatory Bowel Disease

Dietary Options for Inflammatory Bowel Disease Dietary Options for Inflammatory Bowel Disease Michael J. Rosen, MD, MSCI Schubert-Martin Inflammatory Bowel Disease Center Learning objectives Worldwide rise in the incidence of IBD The relationship between

More information

Studies on inflammatory bowel disease and functional gastrointestinal disorders in children and adults Hoekman, D.R.

Studies on inflammatory bowel disease and functional gastrointestinal disorders in children and adults Hoekman, D.R. UvA-DARE (Digital Academic Repository) Studies on inflammatory bowel disease and functional gastrointestinal disorders in children and adults Hoekman, D.R. Link to publication Citation for published version

More information

The Incidence Rate of Inflammatory Bowel Disease in an Urban Area of Iran: A Developing Country

The Incidence Rate of Inflammatory Bowel Disease in an Urban Area of Iran: A Developing Country 32 Original Article The Incidence Rate of Inflammatory Bowel Disease in an Urban Area of Iran: A Developing Country Mohammad Javad Zahedi 1, Sodaif Darvish Moghadam 1, Mehdi Hayat Bakhsh Abbasi 1, Masood

More information

11/13/11. Biologics for CD and CUC: The Impact on Surgical Outcomes. Principles of Successful Intestinal Surgery

11/13/11. Biologics for CD and CUC: The Impact on Surgical Outcomes. Principles of Successful Intestinal Surgery Biologics for CD and CUC: The Impact on Surgical Outcomes Robert R. Cima, M.D., M.A. Associate Professor of Surgery Division of Colon and Rectal Surgery Overview Antibody based medications (biologics)

More information

Epidemiology of Inflammatory Bowel Disease

Epidemiology of Inflammatory Bowel Disease Epidemiology of Inflammatory Bowel Disease Edward V. Loftus, Jr., M.D. Professor of Medicine Division of Gastroenterology and Hepatology Mayo Clinic Rochester, Minnesota, U.S.A. 2010 MFMER slide-1 Loftus

More information

Treatment of Inflammatory Bowel Disease. Michael Weiss MD, FACG

Treatment of Inflammatory Bowel Disease. Michael Weiss MD, FACG Treatment of Inflammatory Bowel Disease Michael Weiss MD, FACG What is IBD? IBD is an immune-mediated chronic intestinal disorder, characterized by chronic or relapsing inflammation within the GI tract.

More information

Towards Precision Medicine in Inflammatory Bowel Diseases

Towards Precision Medicine in Inflammatory Bowel Diseases Precision Medicine and Biomarkers Leaders Summit. Munich September 13-14, 2018 Towards Precision Medicine in Inflammatory Bowel Diseases ANDRÉS HURTADO-LORENZO, Ph.D. SENIOR DIRECTOR OF TRANSLATIONAL RESEARCH

More information

IBD Understanding Your Medications. Thomas V. Aguirre, MD Santa Barbara GI Consultants

IBD Understanding Your Medications. Thomas V. Aguirre, MD Santa Barbara GI Consultants IBD Understanding Your Medications Thomas V. Aguirre, MD Santa Barbara GI Consultants IBD Understanding Your Medications (& Your Doctor) Thomas V. Aguirre, MD Santa Barbara GI Consultants Disclosure I

More information

Implementation of disease and safety predictors during disease management in UC

Implementation of disease and safety predictors during disease management in UC Implementation of disease and safety predictors during disease management in UC DR ARIELLA SHITRIT DIGESTIVE DISEASES INSTITUTE SHAARE ZEDEK MEDICAL CENTER JERUSALEM Case presentation A 52 year old male

More information

Page 1. Global trends in diet parallel IBD. Is there an anti-inflammatory diet for IBD? Patients want to know. Challenges in establishing causality

Page 1. Global trends in diet parallel IBD. Is there an anti-inflammatory diet for IBD? Patients want to know. Challenges in establishing causality Is there an anti-inflammatory diet for IBD? Why diet? Global trends in diet parallel IBD Ashwin N Ananthakrishnan, MD, MPH Director, Crohn s and Colitis Center Assistant Professor of Medicine Massachusetts

More information

Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease

Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease Aliment Pharmacol Ther 23; 18 (Suppl. 2): 1 5. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease P. MUNKHOLM Department of Medical Gastroenterology, Hvidovre

More information

The effectiveness of telephone reminders and SMS messages on compliance with colorectal cancer screening: an open-label, randomized controlled trial

The effectiveness of telephone reminders and SMS messages on compliance with colorectal cancer screening: an open-label, randomized controlled trial Page1 of 5 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 The effectiveness of telephone reminders and SMS messages on compliance with colorectal cancer screening: an

More information

Mortality in vegetarians and comparable nonvegetarians in the United Kingdom 1 3

Mortality in vegetarians and comparable nonvegetarians in the United Kingdom 1 3 See corresponding editorial on page 3. Mortality in vegetarians and comparable nonvegetarians in the United Kingdom 1 3 Paul N Appleby, Francesca L Crowe, Kathryn E Bradbury, Ruth C Travis, and Timothy

More information

The use of omega-3 fatty acids in the management of cancer cachexia. Rhys White Principal Oncology Dietitian Guys and St Thomas NHS Foundation Trust

The use of omega-3 fatty acids in the management of cancer cachexia. Rhys White Principal Oncology Dietitian Guys and St Thomas NHS Foundation Trust The use of omega-3 fatty acids in the management of cancer cachexia Rhys White Principal Oncology Dietitian Guys and St Thomas NHS Foundation Trust Overview Cancer cachexia Clinical features Pathogenesis

More information

PROFILE OF ULCERATIVE COLITIS IN SOUTH INDIAN REGION: KARAIKAL D.BADMAPRIYA*, V.SATHISH KUMAR 1

PROFILE OF ULCERATIVE COLITIS IN SOUTH INDIAN REGION: KARAIKAL D.BADMAPRIYA*, V.SATHISH KUMAR 1 Page47 Available Online through IJPBS Volume 1 Issue 2 APRIL- JUNE 2011 PROFILE OF ULCERATIVE COLITIS IN SOUTH INDIAN REGION: KARAIKAL D.BADMAPRIYA*, V.SATHISH KUMAR 1 * PHARMACIST, GOVERNMENT GENERAL

More information

Inflammatory Bowel Diseases (IBD) Clinical aspects Nitsan Maharshak M.D., IBD Center, Department of Gastroenterology and Liver Diseases Tel Aviv Soura

Inflammatory Bowel Diseases (IBD) Clinical aspects Nitsan Maharshak M.D., IBD Center, Department of Gastroenterology and Liver Diseases Tel Aviv Soura Inflammatory Bowel Diseases (IBD) Clinical aspects Nitsan Maharshak M.D., IBD Center, Department of Gastroenterology and Liver Diseases Tel Aviv Sourasky Medical Center Tel Aviv, Israel IBD- clinical features

More information

Insurance problems among inflammatory bowel disease patients: results of a Dutch population based study

Insurance problems among inflammatory bowel disease patients: results of a Dutch population based study 358 INFLAMMATORY BOWEL DISEASE Insurance problems among inflammatory bowel disease patients: results of a Dutch population based study MGVMRussel, B M Ryan, P C Dagnelie, M de Rooij, J Sijbrandij, A Feleus,

More information

Treatment of Pediatric IBD: What is Different?

Treatment of Pediatric IBD: What is Different? Treatment of Pediatric IBD: What is Different? January 13, 2017 Michael Kappelman MD, MPH University of North Carolina at Chapel Hill Overview Is Pediatric IBD the same disease? Treatment considerations

More information

Personalized Medicine in IBD: Where Are We in 2013

Personalized Medicine in IBD: Where Are We in 2013 Personalized Medicine in IBD: Where Are We in 2013 David A. Schwartz, MD Director, Inflammatory Bowel Disease Center Associate Professor of Medicine Vanderbilt University Medical Center What is Personalized

More information

Formulations and Availability 900 BILLION 5,319 HIGH POTENCY PROBIOTIC PEDIATRIC ADULT GERIATRIC PROVEN BY RESEARCH. HIGH-POTENCY. NO SHORTCUTS.

Formulations and Availability 900 BILLION 5,319 HIGH POTENCY PROBIOTIC PEDIATRIC ADULT GERIATRIC PROVEN BY RESEARCH. HIGH-POTENCY. NO SHORTCUTS. Formulations and Availability S TU D I E S PE R D I S E A S E 39 LIVER Liver Disease, Cirrhosis, Liver Failure, Hepatic Encephalopathy S TU D I E S PE R AG E G RO U P Visbiome Regular Product Code: 693-0412-01

More information

Food Diversity in the First Year of Life and the Development of Allergic Disease in High-Risk Children. By Cheryl Hirst. Supervisor: Dr.

Food Diversity in the First Year of Life and the Development of Allergic Disease in High-Risk Children. By Cheryl Hirst. Supervisor: Dr. Food Diversity in the First Year of Life and the Development of Allergic Disease in High-Risk Children By Cheryl Hirst Supervisor: Dr. Meghan Azad A Capstone Project Submitted to the Faculty of Graduate

More information

Nutrition and IBD. IBD Talk. Presented by. Hannah Price, paediatric dietitian at RHH. Lauren Farquhar, adult dietitian at RHH

Nutrition and IBD. IBD Talk. Presented by. Hannah Price, paediatric dietitian at RHH. Lauren Farquhar, adult dietitian at RHH Nutrition and IBD IBD Talk Presented by Hannah Price, paediatric dietitian at RHH Hannah.price@ths.tas.gov.au Lauren Farquhar, adult dietitian at RHH Lauren.farquhar@ths.tas.gov.au Microbiota and IBD The

More information

Beyond Anti TNFs: positioning of other biologics for Crohn s disease. Christina Ha, MD Cedars Sinai Inflammatory Bowel Disease Center

Beyond Anti TNFs: positioning of other biologics for Crohn s disease. Christina Ha, MD Cedars Sinai Inflammatory Bowel Disease Center Beyond Anti TNFs: positioning of other biologics for Crohn s disease Christina Ha, MD Cedars Sinai Inflammatory Bowel Disease Center Objectives: To define high and low risk patient and disease features

More information

Fistulizing Crohn s Disease: The Aggressive Approach

Fistulizing Crohn s Disease: The Aggressive Approach Fistulizing Crohn s Disease: The Aggressive Approach Bruce E. Sands, MD, MS MGH Crohn s and Colitis Center and Gastrointestinal Unit Massachusetts General Hospital Boston, USA Case Presentation: Summary

More information

Mycobacterium avium subsp. paratuberculosis

Mycobacterium avium subsp. paratuberculosis Mycobacterium avium subsp. paratuberculosis Document date: January 2002 1.- INTRODUCTION The Mycobacteriaceae family, although only made up of the genus Mycobacterium, includes numerous species widely

More information

Research Update: Looking for the Answers

Research Update: Looking for the Answers Research Update: Looking for the Answers Ted Denson, M.D. Schubert-Martin Inflammatory Bowel Disease Center Research Support: NIH/NIDDK, CCFA, BMRP Figure 2 Approach to Improve Outcomes for our IBD Patients

More information

Personalized Medicine in IBD

Personalized Medicine in IBD Personalized Medicine in IBD Anita Afzali MD, MPH Assistant Professor of Medicine Director, Inflammatory Bowel Diseases Program University of Washington Harborview Medical Center CCFA April 2 nd, 2016

More information

Dr David Epstein Vincent Pallotti Hospital and University of Cape Town

Dr David Epstein Vincent Pallotti Hospital and University of Cape Town Inflammatory Bowel Disease Management in South Africa in 2016 Pharmaceutical Care Management Association Dr David Epstein Vincent Pallotti Hospital and University of Cape Town Inflammatory Bowel Disease

More information

Epidemiology of hepatitis E infection in Hong Kong

Epidemiology of hepatitis E infection in Hong Kong RESEARCH FUND FOR THE CONTROL OF INFECTIOUS DISEASES Epidemiology of hepatitis E infection in Hong Kong DPC Chan *, KCK Lee, SS Lee K e y M e s s a g e s 1. The overall anti hepatitis E virus (HEV) seropositivity

More information

(Data from the Travel Health Surveillance Section of the Health Protection Agency Communicable Disease Surveillance Centre)

(Data from the Travel Health Surveillance Section of the Health Protection Agency Communicable Disease Surveillance Centre) Travellers Diarrhoea Introduction Travellers diarrhoea (TD) is a syndrome that commonly affects travellers caused by one of several different organisms, the most common being enterotoxigenic Escherichia

More information

children Crohn s disease in MR enterography for GI Complications Microscopy Characterization Primary sclerosing cholangitis Anorectal fistulae

children Crohn s disease in MR enterography for GI Complications Microscopy Characterization Primary sclerosing cholangitis Anorectal fistulae MR enterography for Crohn s disease in children BOAZ KARMAZYN, MD PEDIATRIC RADIOLOGY ASSOCIATE PROFESSOR Characterization Crohn disease Idiopathic chronic transmural IBD Increasing incidence Age 7/100,000

More information

Related Media. Dr. Rubin discusses smoking as a trigger (00:00, MP3 xx MB)

Related Media. Dr. Rubin discusses smoking as a trigger (00:00, MP3 xx MB) Leading Expert Has Answers on Crohn s Disease David T. Rubin M.D., Assistant Professor of Medicine at the University of Chicago Pritzker School of Medicine and leading authority in Crohn s disease and

More information

Fecoprevalence and determinants of Helicobacter pylor infection among asymptomatic children in Myanmar

Fecoprevalence and determinants of Helicobacter pylor infection among asymptomatic children in Myanmar International Journal of Gastroenterology, Hepatology, Transplant & Nutrition Original Article Fecoprevalence and determinants of Helicobacter pylor infection among asymptomatic children in Myanmar Hnin

More information

COPD and environmental risk factors other than smoking. 14. Summary

COPD and environmental risk factors other than smoking. 14. Summary COPD and environmental risk factors other than smoking 14. Summary Author : P N Lee Date : 7 th March 2008 1. Objectives and general approach The objective was to obtain a good insight from the available

More information

Nutrition as primary therapy in IBD. Dr Clare Donnellan Leeds General Infirmary

Nutrition as primary therapy in IBD. Dr Clare Donnellan Leeds General Infirmary Nutrition as primary therapy in IBD Dr Clare Donnellan Leeds General Infirmary Case GB 34 year old female Diagnosed with Crohn s in 2002? Extent Offered steroids or surgery Declined both GB Represented

More information

Issues at Hand. Inflammatory Bowel Disease Paradigm. Diet changes the fecal microbiome. Experience with diet in IBD

Issues at Hand. Inflammatory Bowel Disease Paradigm. Diet changes the fecal microbiome. Experience with diet in IBD Diet s Role in IBD David Suskind M.D. Professor of Pediatrics Director of Clinical Gastroenterology Division of Gastroenterology University of Washington Seattle Children s Hospital Issues at Hand Inflammatory

More information

DENOMINATOR: All patients aged 18 and older with a diagnosis of inflammatory bowel disease

DENOMINATOR: All patients aged 18 and older with a diagnosis of inflammatory bowel disease Measure #270: Inflammatory Bowel Disease (IBD): Preventive Care: Corticosteroid Sparing Therapy National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY

More information

INFLAMMATORY BOWEL DISEASE

INFLAMMATORY BOWEL DISEASE 1. Medical Condition INFLAMMATORY BOWEL DISEASE (IBD) specifically includes Crohn s disease (CD) and ulcerative colitis (UC) but also includes IBD unclassified (IBDu), seen in about 10% of cases. These

More information

International Journal of Medical Science and Health Research

International Journal of Medical Science and Health Research A Retrospective Study of Clinicopathological Profiles of Proximal Gastrectomy Vs Distal Gastrectomy in Carcinoma Stomach and Its Incidence in our Population Dr Magesh kumar J 1, Dr V Naveen Kumar 2, Dr

More information

The National Association of Crohn s and Colitis of Trinidad and Tobago CROHN S DISEASE AND ULCERATIVE COLITIS GENERAL PATIENT INFORMATION

The National Association of Crohn s and Colitis of Trinidad and Tobago CROHN S DISEASE AND ULCERATIVE COLITIS GENERAL PATIENT INFORMATION The National Association of Crohn s and Colitis of Trinidad and Tobago CROHN S DISEASE AND ULCERATIVE COLITIS GENERAL PATIENT INFORMATION You are reading this pamphlet because you or someone you known

More information

Title: Evolution of the incidence of inflammatory bowel disease in Southern Spain

Title: Evolution of the incidence of inflammatory bowel disease in Southern Spain Title: Evolution of the incidence of inflammatory bowel disease in Southern Spain Authors: Federico Argüelles-Arias, Dina Chaaro Benallal, Jose Manuel Benítez, Raúl Perea Amarillo, Eva Iglesias, Luisa

More information

5/2/2018 SHOULD DEEP REMISSION BE A TREATMENT GOAL? YES! Disclosures: R. Balfour Sartor, MD

5/2/2018 SHOULD DEEP REMISSION BE A TREATMENT GOAL? YES! Disclosures: R. Balfour Sartor, MD 5/2/218 SHOULD DEEP REMISSION BE A TREATMENT GOAL? YES! Disclosures: R. Balfour Sartor, MD Grant support for preclinical studies: Janssen, Gusto Global, Vedanta, Artizan BALFOUR SARTOR, MD DISTINGUISHED

More information

Complementary & Alternative Therapies in IBD

Complementary & Alternative Therapies in IBD Complementary & Alternative Therapies in IBD Laurie Rosales, APRN-CNP OSU Wexner Medical Center Division of Gastroenterology, Hepatology and Nutrition Complementary & Alternative Probiotics Cannabis Fish

More information

Prevalence of Irritable Bowel Syndrome among Medical Students and Interns in Jeddah, Saudi Arabia

Prevalence of Irritable Bowel Syndrome among Medical Students and Interns in Jeddah, Saudi Arabia Prevalence of Irritable Bowel Syndrome among Medical Students and Interns in Jeddah, Saudi Arabia Mohammed Y Hasosah 1*, Samer A Alamri 2, Faisal A Al-Husayni 2, Rakan M. Aljedaani 2, Mohammad A Zwawy

More information

Breast Cancer in Women from Different Racial/Ethnic Groups

Breast Cancer in Women from Different Racial/Ethnic Groups Cornell University Program on Breast Cancer and Environmental Risk Factors in New York State (BCERF) April 2003 Breast Cancer in Women from Different Racial/Ethnic Groups Women of different racial/ethnic

More information

Azathioprine for Induction and Maintenance of Remission in Crohn s Disease

Azathioprine for Induction and Maintenance of Remission in Crohn s Disease Azathioprine for Induction and Maintenance of Remission in Crohn s Disease William J. Sandborn, MD Chief, Division of Gastroenterology Director, UCSD IBD Center Objectives Azathioprine as induction and

More information

I nflammatory bowel diseases (IBD) are chronic intestinal

I nflammatory bowel diseases (IBD) are chronic intestinal 364 INFLAMMATORY BOWEL DISEASE Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn s disease F Costa, M G Mumolo, L Ceccarelli, M Bellini, M R Romano, C Sterpi,

More information

Diverticular Disease: Looking beyond fiber

Diverticular Disease: Looking beyond fiber Binghamton University The Open Repository @ Binghamton (The ORB) Health & Wellness Studies Faculty Scholarship Decker School of Nursing Fall 10-28-2015 Diverticular Disease: Looking beyond fiber Lina Begdache

More information

Genetic Susceptibility. Objectives. What Causes IBD? Inflammatory Bowel Disease

Genetic Susceptibility. Objectives. What Causes IBD? Inflammatory Bowel Disease 4:45 5:30 pm IBD in Pediatrics SPEAKER Jennifer Strople, MD Presenter Disclosure Information The following relationships exist related to this presentation: Jennifer Strople, MD: Speakers Bureau for AbbVie

More information

Vol 118 Monograph 01 Welding and welding fumes Section 2 Table 2.15

Vol 118 Monograph 01 Welding and welding fumes Section 2 Table 2.15 1 Vol 118 Monograph 01 and welding Table 2.15 Case control studies on and welding/welding (web only) Magnani et al. (1987) United Kingdom, 3 English counties 1959 1963; 1965 1979 99; The cases were men

More information

Disclosures. What Do I Do When Anti-TNF Therapy Is Not Working Anymore? Fadi Hamid, M.D. Saint Luke s GI Specialists

Disclosures. What Do I Do When Anti-TNF Therapy Is Not Working Anymore? Fadi Hamid, M.D. Saint Luke s GI Specialists What Do I Do When Anti-TNF Therapy Is Not Working Anymore? Fadi Hamid, M.D. Saint Luke s GI Specialists Disclosures No financial relationships to disclose. 1 Learning Objectives Case 24M with ileocolonic

More information

Probiotics : What we Know and Where we are Going Next

Probiotics : What we Know and Where we are Going Next Probiotics : What we Know and Where we are Going Next Neerja Hajela, Ph.D. General Manager - Science and Regulatory Affairs Yakult Danone India Pvt. Ltd. Functional Food Market Probiotics an important

More information

Walking, even minimal, lowers death risk!

Walking, even minimal, lowers death risk! Max Institute of Cancer Care Shalimar Bagh, Volume 1 Walking, even minimal, lowers death risk! Regular walking, even when it's below the minimum recommended levels for physical fitness, is associated with

More information

A Retrospective Study of the Drug Prescribing Pattern in Crohn s Disease (CD) in a Tertiary Care Hospital

A Retrospective Study of the Drug Prescribing Pattern in Crohn s Disease (CD) in a Tertiary Care Hospital Research Article Mukunda Narayanareddy 1*,Venkatesh Shanbhag 2, Tara V Shanbhag 3, Ganesh Bhat 4, Smita Shenoy 5, Amoolya Gowda 6. 1. Assistant professor, Department of Pharmacology, M.S. Ramaiah Medical

More information

The New England Journal of Medicine APPENDECTOMY AND PROTECTION AGAINST ULCERATIVE COLITIS

The New England Journal of Medicine APPENDECTOMY AND PROTECTION AGAINST ULCERATIVE COLITIS APPENDECTOMY AND PROTECTION AGAINST ULCERATIVE COLITIS ROLAND E. ANDERSSON, M.D., PH.D., GUNNAR OLAISON, M.D., PH.D., CURT TYSK, M.D., PH.D., AND ANDERS EKBOM, M.D., PH.D. ABSTRACT Background A history

More information

Anne Griffiths MD, FRCPC. SickKids Hospital, University of Toronto. Buenos Aires, August 16, 2014

Anne Griffiths MD, FRCPC. SickKids Hospital, University of Toronto. Buenos Aires, August 16, 2014 Management and Medical Therapies for Crohn disease: strategies to enhance mucosal healing Anne Griffiths MD, FRCPC SickKids Hospital, University of Toronto Buenos Aires, August 16, 2014 New onset Crohn

More information

The international health care burden of cancers of the gastrointestinal tract and liver

The international health care burden of cancers of the gastrointestinal tract and liver The international health care burden of cancers of the gastrointestinal tract and liver William R. Brown 1*, Dennis J. Ahnen 2 1 Department of Medicine, University of Colorado School of Medicine, Denver,

More information

Causes of IBD: The Role of Genetics and Microbes and the Epidemiology of IBD

Causes of IBD: The Role of Genetics and Microbes and the Epidemiology of IBD Causes of IBD: The Role of Genetics and Microbes and the Epidemiology of IBD James D. Lewis, MD, MSCE Professor of Medicine and Epidemiology Perelman School of Medicine at the University of Pennsylvania

More information

The prevalence of atopic diseases in childhood

The prevalence of atopic diseases in childhood Paediatrica Indonesiana VOLUME 54 March NUMBER 2 Original Article Caesarean delivery and risk of developing atopic diseases in children Anak Agung Tri Yuliantini 1, Mohammad Juffrie 2, Ketut Dewi Kumara

More information